Product Information
BACLOFEN 5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0680 per EA under NDC 70710160901. Its NADAC has been published 305 times since Dec 2, 2020.
FDA first approved this application on Nov 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710160901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BACLOFENApproval Type
Generic (ANDA)
FDA Application
ANDA211659FDA Approved
11/23/2018
TE Code
AB
On Market Since
5/7/2020
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 5 MG TABLET has been published 305 times since Dec 2, 2020, and over the history we have for it it has declined 92.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0680 per EA |
|---|---|
| All-time high | $0.8809 (Sep 15, 2021) |
| All-time low | $0.0631 (Jul 22, 2026) |
| 52-week high | $0.1075 |
| 52-week low | $0.0631 |
| Median price | $0.1767 |
| Average price | $0.3230 |
| Largest weekly change | +41.7% (Jun 19, 2024) |
| Weeks tracked | 305 |
| Tracking since | Dec 2, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Baclofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACLOFEN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0680 per EA (NDC 70710160901), effective Sep 30, 2026.
How has the price of BACLOFEN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BACLOFEN 5 MG TABLET has declined 92.2%. It has been tracked across 305 weekly CMS publications since Dec 2, 2020.
What are the highest and lowest recorded NADAC prices for BACLOFEN 5 MG TABLET?
Since Dec 2, 2020, the NADAC for BACLOFEN 5 MG TABLET has ranged from a low of $0.0631 (Jul 22, 2026) to a high of $0.8809 (Sep 15, 2021), with a median of $0.1767 per EA.
Are there cheaper alternatives to BACLOFEN 5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BACLOFEN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BACLOFEN 5 MG TABLET?
BACLOFEN 5 MG TABLET (NDC 70710160901) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.